Invesco Ltd. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$7,764,000
+22082.9%
1,501,699
+10979.4%
0.00%
Q1 2021$35,000
+29.6%
13,554
+24.3%
0.00%
Q4 2020$27,000
-94.7%
10,905
-92.7%
0.00%
Q3 2019$513,000
+1408.8%
150,364
+1071.9%
0.00%
Q4 2018$34,000
-52.1%
12,831
+0.8%
0.00%
Q3 2018$71,000
-64.3%
12,732
-67.7%
0.00%
Q2 2018$199,000
-75.5%
39,392
-66.9%
0.00%
Q1 2018$812,000119,0520.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,360,000$6,895,0005.06%
Omega Fund Management, LLC 778,230$3,946,0002.91%
BVF INC/IL 5,346,838$27,108,0002.65%
Virtus ETF Advisers LLC 152,550$773,0000.68%
SPHERA FUNDS MANAGEMENT LTD. 842,632$4,272,0000.59%
Tekla Capital Management LLC 2,087,380$10,583,0000.40%
Schonfeld Strategic Advisors LLC 828,600$4,201,0000.23%
Orbimed Advisors 3,140,000$15,920,0000.19%
Lombard Odier Asset Management (USA) Corp 563,878$2,859,0000.19%
Rhenman & Partners Asset Management AB 300,000$1,521,0000.16%
View complete list of PIERIS PHARMACEUTICALS INC shareholders